Life expectancy for a person with a KRAS mutation in colon cancer depends on several factors, including the stage at diagnosis, overall health, and response to treatment.
Generally, those with KRAS mutations have lower life expectancy than those without the mutation. A 2023 study notes that the overall survival for metastatic colon cancer with a KRAS mutation varies from about 24 to 39 months.